Gilead and South Africa are negotiating a license for local production of new HIV drug

South Africa pushes for local production of HIV prevention drug lenacapavir

South Africa is seeking to produce a key HIV prevention drug locally as part of a broader effort to improve access to treatment and strengthen the country’s pharmaceutical industry.

Gilead and South Africa are negotiating a license for local production of new HIV drug

South Africa has the world’s highest HIV burden with about 8 million HIV-positive people, or 1 in 5 adults, as of last year